CHIRON
LIVE

Serial Number

90575161

Owner

GRIFOLS DIAGNOSTIC SOLUTIONS INC.

Attorney

Ashly I. Boesche

First Use Date

Dec 31, 2023

Filing Date

Mar 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CHIRON Trademark

Serial Number: 90575161 • Registration: 7762606

CHIRON is a trademark filed by GRIFOLS DIAGNOSTIC SOLUTIONS INC. on March 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GRIFOLS DIAGNOSTIC SOLUTIONS INC. (9 trademarks)

EMERYVILLE, CA 94608

Entity Type: 03

Trademark Details

Filing Date

March 12, 2021

Registration Date

April 15, 2025

First Use Anywhere

December 31, 2023

First Use in Commerce

December 31, 2023

Published for Opposition

November 23, 2021

Goods & Services

Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins

Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids

Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods

Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 21, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 21, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 20, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 20, 2025 AITU
USE AMENDMENT FILED
Jan 16, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 16, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 5 GRANTED
May 31, 2024 EX5G
SOU EXTENSION 5 FILED
May 31, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
May 31, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 9, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 9, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 17, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 17, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 11, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 11, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 11, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 14, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 14, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 18, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2021 CNEA
ASSIGNED TO EXAMINER
Oct 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2021 NWOS
NEW APPLICATION ENTERED
Mar 16, 2021 NWAP